Future Science Holdings Etf EBITDA
| FUTS Etf | USD 0.0001 0.00 0.00% |
Future Science Holdings fundamentals help investors to digest information that contributes to Future Science's financial success or failures. It also enables traders to predict the movement of Future Pink Sheet. The fundamental analysis module provides a way to measure Future Science's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Future Science pink sheet.
Future |
Future Science Holdings Company EBITDA Analysis
Future Science's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Future Science EBITDA | (2.57 M) |
Most of Future Science's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Future Science Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, Future Science Holdings reported earnings before interest,tax, depreciation and amortization of (2.57 Million). This is much lower than that of the ProShares family and significantly lower than that of the Managed Futures category. The ebitda for all United States etfs is notably higher than that of the company.
Future EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Future Science's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Future Science could also be used in its relative valuation, which is a method of valuing Future Science by comparing valuation metrics of similar companies.Future Science is rated below average in ebitda as compared to similar ETFs.
Fund Asset Allocation for Future Science
The fund invests most of its assets under management in various types of exotic instruments, with the rest of asset invested in bonds.Asset allocation divides Future Science's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
Future Fundamentals
| Return On Equity | -2.99 | |||
| Return On Asset | -0.82 | |||
| Current Valuation | 105.72 K | |||
| Shares Outstanding | 96.11 M | |||
| Price To Book | 13.01 X | |||
| Gross Profit | 98.87 K | |||
| EBITDA | (2.57 M) | |||
| Net Income | (4.12 M) | |||
| Cash And Equivalents | 677.99 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 1.01 M | |||
| Current Ratio | 4.88 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (3.74 M) | |||
| Earnings Per Share | (0.03) X | |||
| Number Of Employees | 10 | |||
| Beta | 1.06 | |||
| Market Capitalization | 1.23 M | |||
| Z Score | 0.6 | |||
| Year To Date Return | (0.58) % | |||
| One Year Return | 1.53 % | |||
| Net Asset | 7.19 M | |||
| Bond Positions Weight | 12.91 % |
About Future Science Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Future Science Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Future Science using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Future Science Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Future Pink Sheet
Future Science financial ratios help investors to determine whether Future Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Future with respect to the benefits of owning Future Science security.